CIK 0001737287
- Non-accelerated filer
- Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823562771
- Phone
- +1 650-457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-22 | MOORE ALISON Chief Technical Officer | Grant or award | +558,094 | 672,731 | ||
| 2023-03-22 | MOORE ALISON Chief Technical Officer | Grant or award · Stock Option (Right to buy) | +432,738 | 432,738 | ||
| 2023-03-14 | MOORE ALISON Chief Technical Officer | Shares withheld for taxes | −8,351 | $5.51 | $46K | 114,637 |
| 2022-03-23 | MOORE ALISON Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +737,179 | 737,179 | ||
| 2022-03-15 | MOORE ALISON Chief Technical Officer | Sale | −8,698 | $7.63 | $66K | 120,430 |
| 2021-03-26 | MOORE ALISON Chief Technical Officer | Grant or award | +24,866 | 127,440 | ||
| 2021-03-26 | MOORE ALISON Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +92,365 | 92,365 | ||
| 2021-03-15 | MOORE ALISON Chief Technical Officer | Sale | −6,164 | $38.14 | $235K | 102,574 |
| 2020-10-13 | MOORE ALISON Chief Technical Officer | Option exercise | +11,031 | $2.27 | $25K | 119,401 |
| 2020-10-13 | MOORE ALISON Chief Technical Officer | Sale | −11,031 | $42.00 | $463K | 108,370 |
| 2020-10-13 | MOORE ALISON Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −11,031 | 579,959 | ||
| 2020-10-12 | MOORE ALISON Chief Technical Officer | Option exercise | +24,233 | $2.27 | $55K | 132,603 |
| 2020-10-12 | MOORE ALISON Chief Technical Officer | Sale | −24,233 | $42.00 | $1.0M | 108,370 |
| 2020-10-12 | MOORE ALISON Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −24,233 | 590,990 | ||
| 2020-10-09 | MOORE ALISON Chief Technical Officer | Option exercise | +30,199 | $2.27 | $69K | 147,879 |
| 2020-10-09 | MOORE ALISON Chief Technical Officer | Sale | −39,509 | $41.00 | $1.6M | 108,370 |
| 2020-10-09 | MOORE ALISON Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −30,199 | 615,223 | ||
| 2020-10-08 | MOORE ALISON Chief Technical Officer | Option exercise | +5,065 | $2.27 | $11K | 122,745 |
| 2020-10-08 | MOORE ALISON Chief Technical Officer | Sale | −5,065 | $41.00 | $208K | 117,680 |
| 2020-10-08 | MOORE ALISON Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −5,065 | 645,422 |
Page 1 of 3 · 54 trades